A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pert... by Marlow, R, Kuriyakose, S, Mesaros, N, Han, HH, Tomlinson, R, Faust, SN, Snape, MD, Pollard, AJ, Finn, A